Profile | GDS2987 / GI_19557655-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 6.7 | 24 |
GSM215244 | HMVEC_vehicle_rep2 | 19.2 | 44 |
GSM215253 | HMVEC_vehicle_rep3 | 21.5 | 55 |
GSM215254 | HMVEC_atorvastatin_rep1 | 2.6 | 7 |
GSM215282 | HMVEC_atorvastatin_rep3 | 42.8 | 65 |
GSM215344 | HMVEC_atorvastatin_rep2 | 4 | 11 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 22.3 | 40 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 29.7 | 51 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 50.7 | 61 |
GSM215294 | HMVEC_SLx2119_rep1 | 8.9 | 32 |
GSM215295 | HMVEC_SLx2119_rep2 | 5.2 | 11 |
GSM215296 | HMVEC_SLx2119_rep3 | 66.9 | 68 |
GSM215297 | PASMC_vehicle_rep1 | 28.4 | 41 |
GSM215298 | PASMC_vehicle_rep2 | 19.7 | 30 |
GSM215310 | PASMC_vehicle_rep3 | 15.4 | 25 |
GSM215311 | PASMC_atorvastatin_rep1 | 12.5 | 22 |
GSM215312 | PASMC_atorvastatin_rep2 | 19.2 | 30 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 45.1 | 58 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 55.1 | 66 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 51.5 | 63 |
GSM215327 | PASMC_SLx2119_rep1 | 33.9 | 50 |
GSM215328 | PASMC_SLx2119_rep2 | 30.3 | 48 |
GSM215329 | PASMC_SLx2119_rep3 | 3.3 | 7 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 26.4 | 56 |
GSM215332 | Fibroblasts_vehicle_rep3 | 19.6 | 52 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 12.3 | 32 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 17.2 | 43 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 9.5 | 31 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | 37.8 | 65 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 30.4 | 60 |
GSM215341 | Fibroblasts_SLx2119_rep3 |